BSE Live
Nov 06, 16:01Prev. Close
273.20
Open Price
277.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 06, 15:56Prev. Close
270.95
Open Price
271.20
Bid Price (Qty.)
264.45 (2509)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Indoco Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.74 | 1,218.61 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.74 | 1,218.61 | |
| Total Operating Revenues | 1,664.92 | 1,817.29 | 1,668.61 | 1,540.75 | 1,241.53 | |
| Other Income | 5.45 | 9.85 | 2.34 | 2.33 | 3.12 | |
| Total Revenue | 1,670.37 | 1,827.13 | 1,670.95 | 1,543.08 | 1,244.64 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 396.27 | 485.01 | 412.02 | 393.66 | 303.20 | |
| Purchase Of Stock-In Trade | 140.93 | 115.66 | 102.72 | 89.43 | 63.04 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -39.02 | -41.48 | 6.55 | -26.30 | -12.13 | |
| Employee Benefit Expenses | 394.05 | 361.93 | 322.58 | 293.70 | 274.02 | |
| Finance Costs | 66.23 | 38.02 | 25.03 | 14.14 | 22.26 | |
| Depreciation And Amortisation Expenses | 113.84 | 91.87 | 70.61 | 78.96 | 73.13 | |
| Other Expenses | 673.43 | 651.86 | 538.64 | 462.92 | 389.13 | |
| Total Expenses | 1,745.74 | 1,702.86 | 1,478.15 | 1,306.51 | 1,112.65 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -75.36 | 124.27 | 192.79 | 236.57 | 132.00 | |
| Exceptional Items | 0.99 | 11.53 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -74.37 | 135.80 | 192.79 | 236.57 | 132.00 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.47 | 33.17 | 55.51 | 93.30 | 38.57 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 3.11 | 5.62 | -4.96 | -11.53 | 0.38 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 3.58 | 38.79 | 50.54 | 81.77 | 38.95 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -77.95 | 97.00 | 142.25 | 154.80 | 93.05 | |
| Profit/Loss From Continuing Operations | -77.95 | 97.00 | 142.25 | 154.80 | 93.05 | |
| Profit/Loss For The Period | -77.95 | 97.00 | 142.25 | 154.80 | 93.05 | |
| Minority Interest | 4.21 | 1.46 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | -73.74 | 98.46 | 142.25 | 154.80 | 93.05 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -8.00 | 11.00 | 15.00 | 17.00 | 10.00 | |
| Diluted EPS (Rs.) | -8.00 | 11.00 | 15.00 | 17.00 | 10.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 13.83 | 20.73 | 20.73 | 13.82 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 2.76 |
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
27.05.2025
Indoco Remedies Consolidated March 2025 Net Sales at Rs 390.21 crore, down 13.22% Y-o-Y
22.05.2025
Indoco Remedies Standalone March 2025 Net Sales at Rs 347.25 crore, down 22.05% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher